We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$74.6B
AUM Growth
+$11.6B
Cap. Flow
+$749M
Cap. Flow %
1%
Top 10 Hldgs %
23.84%
Holding
3,748
New
262
Increased
1,669
Reduced
1,459
Closed
235

Sector Composition

Rank Sector Weight
1 Technology 14.03%
2 Healthcare 8.95%
3 Financials 8.03%
4 Consumer Discretionary 6.23%
5 Industrials 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCH
3176
Dauch Corp
DCH
$1.64B
$148K ﹤0.01%
19,504
+2,687
+16% +$15.5K
CB icon
3177
CALL
Chubb
CB
$134B
$148K ﹤0.01%
55,800
-22,600
-29% -$2.62M
GLAD icon
3178
Gladstone Capital
GLAD
$446M
$148K ﹤0.01%
10,100
-500
-5% -$6.64K
SRPT icon
3179
PUT
Sarepta Therapeutics
SRPT
$1.92B
$148K ﹤0.01%
23,100
AA icon
3180
Alcoa
AA
$14.3B
$147K ﹤0.01%
13,075
-3,322
-20% -$29.7K
KIO
3181
KKR Income Opportunities Fund
KIO
$460M
$147K ﹤0.01%
11,920
VSTO
3182
DELISTED
Vista Outdoor Inc.
VSTO
$146K ﹤0.01%
+10,104
New +$101K
EVF
3183
Eaton Vance Senior Income Trust
EVF
$91.2M
$144K ﹤0.01%
27,046
+42
+0.2% +$215
IAG icon
3184
IAMGOLD
IAG
$10.4B
$144K ﹤0.01%
36,250
ARI
3185
Apollo Commercial Real Estate
ARI
$880M
$142K ﹤0.01%
14,509
-436
-3% -$3.7K
BBY icon
3186
CALL
Best Buy
BBY
$17.6B
$142K ﹤0.01%
+70,300
New +$5.33M
MGNI icon
3187
Magnite
MGNI
$3.48B
$142K ﹤0.01%
+21,258
New +$133K
PRVB
3188
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$142K ﹤0.01%
+10,064
New +$127K
DHC
3189
Diversified Healthcare Trust
DHC
$1.97B
$141K ﹤0.01%
31,976
-2,750
-8% -$9.72K
GOL
3190
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$141K ﹤0.01%
+20,750
New +$109K
WPRT
3191
Westport Fuel Systems
WPRT
$36.7M
$139K ﹤0.01%
11,188
-150
-1% -$1.68K
XHR
3192
Xenia Hotels & Resorts
XHR
$1.72B
$139K ﹤0.01%
14,878
-36,409
-71% -$339K
ACBI
3193
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$138K ﹤0.01%
11,355
+23
+0.2% +$264
NKG
3194
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
$137K ﹤0.01%
+11,252
New +$133K
NAT icon
3195
Nordic American Tanker
NAT
$1.31B
$136K ﹤0.01%
+33,583
New +$159K
ACH
3196
Accendra Health
ACH
$95.7M
$136K ﹤0.01%
17,903
APTS
3197
DELISTED
Preferred Apartment Communities, Inc.
APTS
$136K ﹤0.01%
17,943
+2,846
+19% +$20.7K
NGD
3198
DELISTED
New Gold Inc
NGD
$134K ﹤0.01%
98,978
-7,955
-7% -$7.98K
ADAM
3199
Adamas Trust
ADAM
$919M
$133K ﹤0.01%
12,727
+385
+3% +$3.38K
WRAP icon
3200
Wrap Technologies
WRAP
$105M
$133K ﹤0.01%
+12,655
New +$75.8K

Similar funds

Raymond James & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Raymond James & Associates held 3,748 positions worth $74.6B, up 18% from $63B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2020 filing shows 262 new, 1,669 increased, 1,459 reduced and 235 closed positions. Its largest new stake was Carrier Global: 1,148,017 shares worth $25.5M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $487M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2020 buy was Carrier Global: 1,148,017 shares worth $25.5M.
  • Raymond James & Associates added most to iShares Broad USD High Yield Corporate Bond ETF in Q2 2020, an estimated $312M increase.
  • Raymond James & Associates's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $487M.
  • Raymond James & Associates fully exited Raytheon Company in Q2 2020, selling an estimated $73.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $74.6B portfolio in Q2 2020.
  • Raymond James & Associates opened 262 new positions and closed 235 in Q2 2020.
  • Raymond James & Associates's portfolio value rose 18% quarter-over-quarter to $74.6B.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.